Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 4:07 pm Sale | 2025-10-28 | 13G | CO-DIAGNOSTICS INC CODX | Orca Capital AG | 74,939 3.700% | -125,099 (-62.54%) | Filing History |
| 2025-10-30 4:05 pm Purchase | 2025-10-28 | 13G | CO-DIAGNOSTICS INC CODX | Orca Capital AG | 200,038 9.900% | 126,914 (+173.56%) | Filing History |
| 2025-09-19 4:05 pm Sale | 2025-09-18 | 13G | CO-DIAGNOSTICS INC CODX | Orca Capital AG | 73,124 4.600% | -87,193 (-54.39%) | Filing History |
| 2025-09-18 4:05 pm Purchase | 2025-09-17 | 13G | CO-DIAGNOSTICS INC CODX | Orca Capital AG | 160,317 9.900% | 160,317 (New Position) | Filing History |
| 2025-09-15 5:23 pm Sale | 2025-09-11 | 13G | SILEXION THERAPEUTICS CORP SLXN | Orca Capital AG | 10,943 4.900% | -2,182 (-16.62%) | Filing History |
| 2025-09-15 5:19 pm Purchase | 2025-09-11 | 13G | SILEXION THERAPEUTICS CORP SLXN | Orca Capital AG | 13,125 6.200% | 13,125 (New Position) | Filing History |
| 2025-09-09 4:24 pm Sale | 2025-09-04 | 13G | PURPLE BIOTECH LTD SPONSORED A PPBT | Orca Capital AG | 30,639 4.900% | -29,861 (-49.36%) | Filing History |
| 2025-09-09 4:18 pm Purchase | 2025-09-04 | 13G | PURPLE BIOTECH LTD SPONSORED A PPBT | Orca Capital AG | 60,500 9.900% | 60,500 (New Position) | Filing History |
| 2025-08-07 4:05 pm Sale | 2025-08-04 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Orca Capital AG | 280,642 4.900% | -234,323 (-45.50%) | Filing History |
| 2025-07-23 4:05 pm Sale | 2025-07-22 | 13G | RANI THERAPEUTICS HLDGS INC CO RANI | Orca Capital AG | 1,891,623 4.300% | -2,462,377 (-56.55%) | Filing History |
| 2025-07-17 4:59 pm Sale | 2025-07-15 | 13G | 60 DEGREES PHARMACEUTICALS INC SXTP | Orca Capital AG | 41,557 4.900% | -38,443 (-48.05%) | Filing History |
| 2025-07-17 4:57 pm Purchase | 2025-07-15 | 13G | 60 DEGREES PHARMACEUTICALS INC SXTP | Orca Capital AG | 80,000 9.900% | 80,000 (New Position) | Filing History |
| 2025-07-17 4:56 pm Purchase | 2025-07-14 | 13G | RANI THERAPEUTICS HLDGS INC CO RANI | Orca Capital AG | 4,354,000 9.900% | 4,354,000 (New Position) | Filing History |
| 2025-06-11 4:07 pm Sale | 2025-06-06 | 13G | VENUS CONCEPT INC PAR $0.0 VERO | Orca Capital AG | 101,748 4.900% | -6,932 (-6.38%) | Filing History |
| 2025-06-11 4:05 pm Purchase | 2025-06-06 | 13G | VENUS CONCEPT INC PAR $0.0 VERO | Orca Capital AG | 108,680 5.900% | 108,680 (New Position) | Filing History |
| 2025-05-09 4:36 pm Sale | 2025-05-07 | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Orca Capital AG | 362,857 4.900% | -8,285 (-2.23%) | Filing History |
| 2025-05-09 4:31 pm Purchase | 2025-05-06 | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Orca Capital AG | 371,142 5.700% | 371,142 (New Position) | Filing History |
| 2025-04-23 4:30 pm Sale | 2025-04-22 | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Orca Capital AG | 7,869,135 4.100% | -10,880,865 (-58.03%) | Filing History |
| 2025-04-16 4:30 pm Purchase | 2025-04-14 | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Orca Capital AG | 18,750,000 9.700% | 18,750,000 (New Position) | Filing History |
| 2025-04-14 4:30 pm Sale | 2025-04-11 | 13G | VENUS CONCEPT INC PAR $0.0 VERO | Orca Capital AG | 0 0.000% | -83,429 (Position Closed) | Filing History |